The treatment of Campylobacter-associated gastritis.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001729:Bismuth; D002169:Campylobacter Infections / Q000188:drug therapy*; D004917:Erythromycin / Q000031:analogs & derivatives / Q000627:therapeutic use; D015643:Erythromycin Ethylsuccinate; D005756:Gastritis / Q000188:drug therapy*; D006801:Humans; D009942:Organometallic Compounds / Q000627:therapeutic use; D012459:Salicylates / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D009942:Organometallic Compounds; D012459:Salicylates; D015643:Erythromycin Ethylsuccinate; C015715:bismuth subsalicylate; D004917:Erythromycin; D001729:Bismuth